Clinical study of dexmedetomidine combined with acupuncture on postoperative intestinal function protection in patients with colorectal cancer

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2200063720

Enrollment

Unknown

Registered

2022-09-15

Start date

2022-09-15

Completion date

Unknown

Last updated

2023-04-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

colorectal cancer

Interventions

Group 1 :Dexmedetomidine + Acupuncture

Group 2:Dexmedetomidine

Group 3:Acupuncture

Eligibility

Sex/Gender

All

Age

18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Postoperative pathological examination confirmed colorectal cancer; 2. Preoperative radiotherapy and chemotherapy were not received.

Exclusion criteria

Exclusion criteria: 1. Complicated with severe tissue infection or tissue immune disease; 2. Complicated with severe organ dysfunction; 3. Combined with mental illness or communication disorder.

Design outcomes

Primary

Measure	Time frame
Mean arterial pressure;Heart rate;Dosage of narcotic drugs;Adverse events;Visual analogue scale;QoR-40 scale to evaluate the quality of recovery;Interleukin-6;Tumor necrosis factor-a;Superoxide dismutase;Malondialdehyde;Diamine oxidase;D-lactic acid;Quantification of Escherichia coli;Quantification of Bifidobacterium;	—

Countries

China

Contacts

Public ContactXie Yubo

The First Affiliated Hospital of Guangxi Medical University

xybdoctor@163.com+86 13977121557

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026